These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12509761)

  • 1. The common technical document: the changing face of the New Drug Application.
    Molzon J
    Nat Rev Drug Discov; 2003 Jan; 2(1):71-4. PubMed ID: 12509761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Conference on Harmonisation; guidance on ethnic factors in the acceptability of foreign clinical data; availability--FDA. Notice.
    Fed Regist; 1998 Jun; 63(111):31790-6. PubMed ID: 10180134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice.
    Fed Regist; 1998 Sep; 63(185):51074-84. PubMed ID: 10185809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Investigators' Brochure: a comparison of the draft international conference on harmonisation guideline with current Food and Drug Administration requirements.
    Cocchetto DM
    Qual Assur; 1995 Dec; 4(4):240-6. PubMed ID: 8890349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value and benefits of the International Conference on Harmonisation to drug regulatory authorities: advancing harmonization for better public health.
    Molzon JA; Giaquinto A; Lindstrom L; Tominaga T; Ward M; Doerr P; Hunt L; Rago L
    Clin Pharmacol Ther; 2011 Apr; 89(4):503-12. PubMed ID: 21326288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Aug; 76(155):49773-4. PubMed ID: 21834216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry perspectives on ICH guidelines.
    Rockhold FW
    Stat Med; 2002 Oct; 21(19):2949-57. PubMed ID: 12325111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Conference on Harmonisation; draft guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products--FDA. Notice.
    Fed Regist; 1998 Jun; 63(110):31506-13. PubMed ID: 10180131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study critiques corporate control of trials.
    Niiler E
    Nat Biotechnol; 2002 Dec; 20(12):1180. PubMed ID: 12454659
    [No Abstract]   [Full Text] [Related]  

  • 11. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Feb; 77(34):9948-9. PubMed ID: 22379685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 Nov; 77(224):69634-5. PubMed ID: 23227566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audience with Thomas Lönngren. Interview by Asher Mullard.
    Lönngren T
    Nat Rev Drug Discov; 2010 Dec; 9(12):912. PubMed ID: 21119726
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory constraints as seen from the pharmaceutical industry.
    Galligani G; David-Andersen I; Fossum B
    Dev Biol (Basel); 2005; 121():235-41. PubMed ID: 15962486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Mar; 75(44):10487-8. PubMed ID: 20383918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
    Kock M; Thomsen MK
    Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.